Literature DB >> 2433716

Specific substance P binding sites in rat thymus and spleen: in vitro autoradiographic study.

K Shigematsu, J M Saavedra, M Kurihara.   

Abstract

Substance P binding sites were localized in rat thymus and spleen by incubation of tissue sections with [125I]Bolton-Hunter substance P, [3H]Ultrofilm autoradiography with image analysis coupled to computerized microdensitometry and comparison with 125I standards. The tissue localization of the binding sites was determined with emulsion autoradiography. A single type of specific, saturable, high affinity binding sites was found associated with the vasculature in the medulla of the thymus and the marginal sinus of the spleen, with a Kd of 0.10 and 0.14 nM, respectively. Of all the unlabeled tachykinins tested (substance P, physalaemin, substance K, eledoisin, kassinin, and neuromedin K) substance P was the most potent inhibitor of [125I]Bolton-Hunter substance P binding, with an IC50 of approximately 0.5 nM, indicating the presence of substance P-P binding sites. Our results support the hypothesis of a role for substance P in the modulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433716     DOI: 10.1016/0167-0115(86)90058-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  4 in total

Review 1.  The thymic education of developing T cells in self neuroendocrine principles.

Authors:  V Geenen; F Robert; H Martens; D De Groote; P Franchimont
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

2.  Visualization of the thymus by substance P receptor scintigraphy in man.

Authors:  P M van Hagen; W A Breeman; J C Reubi; P T Postema; P J van den Anker-Lugtenburg; D J Kwekkeboom; J Laissue; B Waser; S W Lamberts; T J Visser; E P Krenning
Journal:  Eur J Nucl Med       Date:  1996-11

Review 3.  Peptides in the mammalian cardiovascular system.

Authors:  J Wharton; S Gulbenkian
Journal:  Experientia       Date:  1987-07-15

Review 4.  The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy.

Authors:  Agnieszka Majkowska-Pilip; Paweł Krzysztof Halik; Ewa Gniazdowska
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.